| Product Code: ETC13236630 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Airway/Lung Stent Market was valued at USD 1.2 Billion in 2024 and is expected to reach USD 2.9 Billion by 2031, growing at a compound annual growth rate of 12.30% during the forecast period (2025-2031).
The Global Airway/Lung Stent Market is expected to experience significant growth in the coming years due to the rising prevalence of respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), and asthma. Airway/lung stents are medical devices used to open up blocked airways, provide support to weakened airways, and maintain airflow in the lungs. Factors driving market growth include advancements in stent technology, increasing awareness about minimally invasive procedures, and a growing aging population. Key players in the market are focused on developing innovative stent designs and materials to improve patient outcomes and minimize complications. Geographically, North America and Europe are expected to dominate the market due to the high prevalence of respiratory diseases and well-established healthcare infrastructure.
The Global Airway/Lung Stent Market is experiencing growth due to increasing prevalence of respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), and asthma. Technological advancements in stent design and materials, along with rising adoption of minimally invasive procedures, are driving market expansion. Key opportunities in the market include the development of biodegradable stents, expanding applications beyond traditional indications, and increasing focus on personalized treatment options. The growing aging population and rising awareness about respiratory health are also contributing to market growth. However, challenges such as high costs associated with stent placement procedures and potential complications may hinder market progress. Overall, the market is poised for continued growth with a focus on innovation and improving patient outcomes.
The Global Airway/Lung Stent Market faces several challenges, including limited awareness among healthcare professionals and patients about the benefits of airway/lung stents, leading to underdiagnosis and underutilization of these devices. Additionally, the high cost of airway/lung stents and the lack of reimbursement policies in some regions can hinder market growth. Another challenge is the risk of complications associated with stent placement, such as migration, tissue overgrowth, and infection, which may deter both healthcare providers and patients from opting for stent implantation. Furthermore, the relatively small market size and the presence of alternative treatment options, such as surgery or medication, pose competitive challenges for airway/lung stent manufacturers in terms of market penetration and adoption.
The Global Airway/Lung Stent Market is primarily driven by the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), lung cancer, and other respiratory conditions. The rising adoption of minimally invasive procedures for the treatment of these conditions, coupled with technological advancements in stent design and materials, is also fueling market growth. Additionally, the growing elderly population worldwide, who are more prone to respiratory complications, is contributing to the demand for airway/lung stents. Furthermore, the expanding healthcare infrastructure in emerging economies and the increasing awareness about the benefits of stent placement for airway management are expected to drive the market further in the coming years.
Government policies related to the Global Airway/Lung Stent Market primarily focus on regulating the safety, efficacy, and quality of stents used in airway and lung procedures. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the EU require stents to undergo rigorous testing and approval processes before they can be marketed. These policies aim to ensure that stents meet specific standards for performance and patient safety. Additionally, reimbursement policies play a significant role in shaping the market landscape by determining the extent to which stent procedures are covered by public and private health insurance plans, influencing healthcare providers` adoption of these devices. Overall, government policies in this sector are designed to safeguard patient health and promote innovation while balancing cost-effectiveness in healthcare delivery.
The Global Airway/Lung Stent Market is expected to witness significant growth in the coming years due to increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and lung cancer, as well as advancements in stent technology. The market is projected to be driven by rising demand for minimally invasive procedures, growing elderly population, and increasing awareness about the benefits of airway/lung stents in managing respiratory disorders. Additionally, ongoing research and development activities aimed at improving stent design and materials are likely to further boost market growth. However, factors such as high cost of stent procedures and potential complications associated with stent placement may pose challenges to market expansion. Overall, the Global Airway/Lung Stent Market is anticipated to experience steady growth in the foreseeable future.
The Global Airway/Lung Stent Market is witnessing significant growth across different regions. In Asia, the market is driven by the increasing prevalence of respiratory diseases and a growing geriatric population. North America leads the market due to advanced healthcare infrastructure and higher adoption of minimally invasive procedures. In Europe, the market is fueled by the rising cases of lung cancer and chronic obstructive pulmonary disease (COPD). The Middle East and Africa region is experiencing a steady growth in the airway/lung stent market, supported by improving healthcare facilities and a rising awareness of respiratory disorders. Latin America is also showing promising growth, driven by the increasing focus on healthcare infrastructure development and the rising demand for innovative medical devices in the region.
Global Airway/Lung Stent Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Airway/Lung Stent Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Airway/Lung Stent Market Revenues & Volume, 2021 & 2031F |
3.3 Global Airway/Lung Stent Market - Industry Life Cycle |
3.4 Global Airway/Lung Stent Market - Porter's Five Forces |
3.5 Global Airway/Lung Stent Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Airway/Lung Stent Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Airway/Lung Stent Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Global Airway/Lung Stent Market Revenues & Volume Share, By Material Type, 2021 & 2031F |
4 Global Airway/Lung Stent Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Airway/Lung Stent Market Trends |
6 Global Airway/Lung Stent Market, 2021 - 2031 |
6.1 Global Airway/Lung Stent Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Airway/Lung Stent Market, Revenues & Volume, By Self-expandable, 2021 - 2031 |
6.1.3 Global Airway/Lung Stent Market, Revenues & Volume, By Balloon-expandable, 2021 - 2031 |
6.1.4 Global Airway/Lung Stent Market, Revenues & Volume, By Non-expandable, 2021 - 2031 |
6.2 Global Airway/Lung Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Airway/Lung Stent Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.2.3 Global Airway/Lung Stent Market, Revenues & Volume, By Ambulatory Surgery Centers, 2021 - 2031 |
6.2.4 Global Airway/Lung Stent Market, Revenues & Volume, By Other End Users, 2021 - 2031 |
6.3 Global Airway/Lung Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Airway/Lung Stent Market, Revenues & Volume, By Metal, 2021 - 2031 |
6.3.3 Global Airway/Lung Stent Market, Revenues & Volume, By Silicone, 2021 - 2031 |
6.3.4 Global Airway/Lung Stent Market, Revenues & Volume, By Hybrid, 2021 - 2031 |
7 North America Airway/Lung Stent Market, Overview & Analysis |
7.1 North America Airway/Lung Stent Market Revenues & Volume, 2021 - 2031 |
7.2 North America Airway/Lung Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Airway/Lung Stent Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Airway/Lung Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 North America Airway/Lung Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
8 Latin America (LATAM) Airway/Lung Stent Market, Overview & Analysis |
8.1 Latin America (LATAM) Airway/Lung Stent Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Airway/Lung Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Airway/Lung Stent Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Airway/Lung Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
8.5 Latin America (LATAM) Airway/Lung Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
9 Asia Airway/Lung Stent Market, Overview & Analysis |
9.1 Asia Airway/Lung Stent Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Airway/Lung Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Airway/Lung Stent Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Airway/Lung Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
9.5 Asia Airway/Lung Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
10 Africa Airway/Lung Stent Market, Overview & Analysis |
10.1 Africa Airway/Lung Stent Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Airway/Lung Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Airway/Lung Stent Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Airway/Lung Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
10.5 Africa Airway/Lung Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
11 Europe Airway/Lung Stent Market, Overview & Analysis |
11.1 Europe Airway/Lung Stent Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Airway/Lung Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Airway/Lung Stent Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Airway/Lung Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
11.5 Europe Airway/Lung Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
12 Middle East Airway/Lung Stent Market, Overview & Analysis |
12.1 Middle East Airway/Lung Stent Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Airway/Lung Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Airway/Lung Stent Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Airway/Lung Stent Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Airway/Lung Stent Market, Revenues & Volume, By End User, 2021 - 2031 |
12.5 Middle East Airway/Lung Stent Market, Revenues & Volume, By Material Type, 2021 - 2031 |
13 Global Airway/Lung Stent Market Key Performance Indicators |
14 Global Airway/Lung Stent Market - Export/Import By Countries Assessment |
15 Global Airway/Lung Stent Market - Opportunity Assessment |
15.1 Global Airway/Lung Stent Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Airway/Lung Stent Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Airway/Lung Stent Market Opportunity Assessment, By End User, 2021 & 2031F |
15.4 Global Airway/Lung Stent Market Opportunity Assessment, By Material Type, 2021 & 2031F |
16 Global Airway/Lung Stent Market - Competitive Landscape |
16.1 Global Airway/Lung Stent Market Revenue Share, By Companies, 2024 |
16.2 Global Airway/Lung Stent Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here